Neuropeptide S, a 20-amino-acid peptide highly conserved in tetrapod vertebrates, binds to the G-protein-coupled neuropeptide S receptor, triggering downstream intracellular calcium elevation, cyclic adenosine monophosphate accumulation, and mitogen-activated protein kinase cascade activation. Across 53 evaluated studies comprising investigations in mice, rats, and human cohorts, the synthesized evidence demonstrates that pharmacological activation or genetic disruption of this signaling axis exerts its most profound behavioral consequences when learned associations compete for expression, including during conditioned fear extinction, memory reinstatement, and contextual generalization.
The methodological framework of the systematic review adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines across four major bibliographic databases up to August 2025 without restrictions on language, publication date, or publication type. After initial screening identified 412 database records alongside nine additional articles, an eligibility filtering process excluded non-English records, non-primary research publications, and investigations examining neurodegenerative conditions or lacking direct behavioral endpoints. Following two-reviewer full-text evaluations designed to assess experimental design, confounding variables, and interpretive validity, 53 primary research articles met all inclusion criteria. The synthesized literature heavily weighted rodent experimental models, encompassing 36 mouse studies and 16 rat studies, while only three investigations evaluated the receptor system in human volunteer cohorts.
Neuroanatomical distribution profiles documented within the reviewed literature emphasize a stark functional contrast between the localized production sites of the peptide and the widespread expression of its receptor. In rodents, neuropeptide S precursor messenger RNA remains confined to restricted brainstem structures, most notably the peri-coerulean region and the lateral parabrachial nucleus, with sparse populations in hypothalamic nuclei and the amygdaloid complex. Conversely, the cognate receptor is densely localized throughout key cognitive and emotional processing structures, including the hippocampus, prefrontal and retro-splenial cortices, paraventricular thalamic nucleus, and basolateral amygdala. Functional manipulations highlighted in the synthesis confirm that this widespread receptor network allows central neuropeptide S release to exert diverse modulatory effects across sensory, affective, and executive neural circuits.
Within aversive associative conditioning paradigms, neuropeptide S signaling demonstrates prominent regulatory control over fear extinction processes rather than baseline memory encoding. Pharmacological administration of neuropeptide S directly into the lateral or basolateral amygdala, the cerebral ventricles, or the ventral tegmental area consistently facilitated the extinction of conditioned fear responses across multiple strains, effectively mitigating stress-induced extinction deficits. Intriguingly, both pharmacological receptor activation and constitutive genetic ablation of the receptor gene produced facilitated extinction profiles in specific experimental contexts, reflecting complex interactions between baseline anxiety states and neural circuit adaptation. In human cohorts, carriers of the functional T allele of the receptor polymorphism exhibited accelerated fear extinction and distinct prefrontal hemodynamic responses, linking genetic variations in receptor activity directly to fear regulation circuitry.
Beyond classical Pavlovian fear conditioning, the systematic review established that neuropeptide S plays an essential modulatory role in inhibitory avoidance and sensorimotor integration. Post-training intracerebroventricular administration of neuropeptide S or synthetic agonist analogs enhanced long-term memory retention in inhibitory avoidance tasks in a dose-dependent manner, confirming an active role during memory consolidation. In startle paradigms, while prepulse inhibition remained largely unaffected by receptor deletion, central neuropeptide S infusion into the amygdala attenuated fear-potentiated startle responses, illustrating an ability to dampen excessive defensive reactions in stressful contexts.
In appetitive operant conditioning models, the systematic review identified a clear dissociation between initial reinforcement learning and subsequent relapse vulnerability. Central administration of neuropeptide S or selective receptor antagonists produced minimal and inconsistent changes in baseline self-administration of rewards, indicating that the endogenous peptide system is not required for primary reinforcement learning. However, during reinstatement testing following extinction, neuropeptide S delivered intracerebroventricularly or locally into the lateral hypothalamus and perifornical area robustly restored extinguished drug-seeking and alcohol-seeking behavior. Selective pharmacological antagonists directed against the receptor successfully attenuated both cue-induced and stress-primed reinstatement of cocaine-seeking, positioning the receptor axis as an important regulator of cue reactivity and motivational drive.
Investigations targeting episodic and short-term memory demonstrated that neuropeptide S signaling facilitates spatial and novel object memory consolidation while mitigating cognitive impairments induced by pharmacological disruption or sleep deprivation. Intracerebroventricular delivery of the peptide restored spatial performance in Morris water maze and olfactory spatial discrimination tasks following administration of the non-competitive N-methyl-D-aspartate receptor antagonist MK801, the muscarinic antagonist scopolamine, or extended sleep restriction. Similarly, post-training neuropeptide S administration prolonged object recognition memory beyond control baseline intervals. Conversely, constitutive receptor knock-out mice displayed significant deficits in novel place and context discrimination tasks, indicating that endogenous receptor signaling supports the encoding and retention of multidimensional environmental cues.
The qualitative synthesis identified extensive functional crosstalk between neuropeptide S and multiple central neurotransmitter systems, demonstrating that its behavioral actions rely on distributed neuromodulatory networks. The pro-reinstatement effects of hypothalamic neuropeptide S infusions depend strictly upon intact hypocretin and orexin transmission, as selective orexin receptor antagonists abolished neuropeptide-driven relapse responses in the paraventricular nucleus and bed nucleus of the stria terminalis. In consolidation tasks, the memory-enhancing actions of neuropeptide S in the basolateral amygdala were completely blocked by systemic or local administration of the beta-adrenergic antagonist propranolol. Furthermore, extinction facilitation within the ventral tegmental area and nucleus accumbens shell correlated with elevated dopamine efflux, while interactions with cannabinoid, corticotropin-releasing factor, and GABAergic circuits mediated stress-related behavioral adaptations.
The authors of the systematic review concluded that the apparent diversity of neuropeptide S actions across distinct cognitive tasks is best understood through a unified framework of behavioral salience attribution. Rather than acting as a universal, non-specific amplifier of synaptic memory traces, neuropeptide S signaling appears to prioritize the behavioral expression of learned associations when internal motivational states or external environmental contingencies shift. Methodological limitations documented within the primary literature—such as disparate behavioral protocols, inconsistent drug dosages, developmental adaptations in constitutive knock-out models, and a heavy historical reliance on male rodent subjects—underscore the necessity for future lifespan and sex-differentiated investigations to fully delineate this neuromodulatory architecture.
Overall, this systematic synthesis provides a coherent neurobiological basis for interpreting how a localized peptide transmitter system coordinates widespread emotional and cognitive processes. By modulating how strongly environmental cues direct behavioral output under conditions of stress, extinction, and reward anticipation, neuropeptide S signaling serves as an essential arbiter of adaptive behavioral flexibility. These mechanistic insights clarify the therapeutic potential of targeting neuropeptide S receptors, presenting promising pharmacological avenues for refining treatment interventions in clinical conditions characterized by persistent maladaptive salience processing, including anxiety disorders, post-traumatic stress, and substance use relapse.
Anatomical localization within the synthesized literature delineates subtle differences across species in how neuropeptide S producing cell bodies are distributed. In rats, the precursor messenger RNA attains peak concentrations within the brainstem peri-coerulean area, the lateral parabrachial nucleus, and the sensory nucleus neurons, while mice lack expression in those sensory neurons. Instead, mouse expression extends across the peri-coerulean area between the lateral parabrachial and Kölliker-Fuse nuclei, the anterior olfactory nucleus, the nucleus incertus, and the anterior hypothalamus. Receptor binding predominantly triggers intracellular calcium and cyclic adenosine monophosphate elevations together with mitogen-activated protein kinase signaling. These molecular pathways govern cellular excitability across terminal regions including the amygdala and cerebral cortex, where the receptor exhibits markedly wider density than the localized peptide producing clusters.
Analysis of experimental cohorts in the systematic review exposed pronounced sample imbalances and methodological constraints across the broader scientific literature. Of the 53 included publications, 35 examined exclusively male subjects, one examined only females, and two omitted reporting subject sex entirely, leaving only 15 studies evaluating both sexes. Among investigations that included both male and female animals, merely six reported sex-specific behavioral divergence. For instance, in female rodents, natural shifts across the estrous cycle produced variable memory latencies in inhibitory avoidance paradigms. In addition, only three studies tested human cohorts, each relying on genetic association paradigms comparing the ancestral gain-of-function isoleucine variant against the human-specific hypofunctional asparagine polymorphism at position 107 of the receptor.
Technical evaluations revealed contrasting behavioral outcomes between constitutive genetic knockouts and acute pharmacological interventions, highlighting significant interpretive complexities. Furthermore, intense physical arousal and hyperlocomotion triggered by pharmacological receptor agonists complicate cognitive assessments unless tasks explicitly isolate locomotor activity from memory retrieval. The absence of protocol pre-registration prior to data collection, alongside varying baseline stress levels across startle testing setups, presents additional limitations that caution against broad generalizations across cognitive domains.
Subject of Research: Preclinical and clinical systematic review of neuropeptide S modulation of learning and memory systems
Article Title: Neuropeptide S modulation of learning and memory: a systematic review
Article References: Caragea, V.-M., Jüngling, K., & Méndez-Couz, M. (2026). Neuropeptide S modulation of learning and memory: a systematic review. Behavioral and Brain Functions, 22(1), Article 17. https://doi.org/10.1186/s12993-026-00336-y
Image Credits: AI Generated
DOI: 10.1186/s12993-026-00336-y
Keywords: Neuropeptide S, NPSR1, learning and memory, fear conditioning, extinction learning, reinstatement, cognitive flexibility, inhibitory avoidance, paraventricular nucleus of the thalamus, basolateral amygdala, dopaminergic signaling, orexinergic signaling, systematic review, behavioral neuroscience, addiction models, anxiety disorders
News Source: Glenn Wilkins. (November 13, 2026). Systematic Review Finds Neuropeptide S Regulates Salience Across Multiple Memory Systems. Scienmag.



